Centessa Pharmaceuticals plc ADR (CNTA) Stock creates opportunities due to its volume and complexity
Jefferies raised the price target for the Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA) stock from “a Hold” to “a Buy”. The rating was released on November 15, 2023, according to finviz. We previously noted in another research note published on October 26, 2023 by Morgan Stanley that upgraded the stock from an Underweight to an Equal-weight […]